EFFICACY OF CANAGLIFLOZIN AS AN ADD-ON TO TRIPLE DRUG TREATMENT WITH GLIMEPIRIDE, METFORMIN AND TENELIGLIPTIN | Zendy

AI Assistant Blog Pricing

Open Access

EFFICACY OF CANAGLIFLOZIN AS AN ADD-ON TO TRIPLE DRUG TREATMENT WITH GLIMEPIRIDE, METFORMIN AND TENELIGLIPTIN

Author(s) -

Pattanaik S.R

Publication year - 2018

Publication title -

journal of evidence based medicine and healthcare

Language(s) - English

Resource type - Journals

eISSN - 2349-2570

pISSN - 2349-2562

DOI - 10.18410/jebmh/2018/425

Subject(s) - medicine , glimepiride , metformin , canagliflozin , drug , pharmacology , type 2 diabetes , endocrinology , diabetes mellitus , insulin

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Download on the

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.